LataMed AI Corp.

Catalyst Crew Technologies Corp. is a development-stage technology company focused on creating and commercializing artificial intelligence-enabled healthcare technology solutions. The company's strategy involves developing an AI healthcare analytics platform and a technology-enabled healthcare services coordination model. These are designed to aid clinical decision-making, patient management, and optimize healthcare delivery by integrating machine learning, data analytics, and software tools for healthcare providers and organizations. Catalyst Crew was incorporated in Nevada on September 11, 2008. Its business focus shifted in February 2026 after acquiring certain healthcare technology assets. As of December 31, 2025, the company had not generated revenue from its current business operations and was still in the development stage. The AI Healthcare Platform is being developed to provide data-driven clinical insights and operational efficiencies. It is intended to use machine learning models, data processing, and analytical tools for areas like disease risk assessment, diagnostic support, and patient monitoring. The technology is designed to be modular and adaptable, integrating with various healthcare data sources, both structured and unstructured. The platform aims to support multiple clinical domains, including cardiovascular, pulmonary, and neurological applications. Current development initiatives include CardioAI, for cardiovascular risk assessment; PulmoAI, for pulmonary condition analysis; and NeuroAI, for neurological condition assessment. These technologies are still under development and have not been commercialized, and the company has not generated revenue from these activities.